Why the study?
What are the differing roles of body mass and the renin-angiotensin system in mediating cardiovascular and renal aspects of hypertension in lean versus overweight patients?
What are the differing roles of body mass and the renin-angiotensin system in mediating cardiovascular and renal aspects of hypertension in lean versus overweight patients?
Cardiovascular and renal changes in overweight hypertensive patients depend chiefly on body weight and insulin, whereas the renin-angiotensin system plays a major role in normal-weight hypertensives.
BACKGROUND: Hypertension is characterized not only by a metabolic syndrome that includes obesity and insulin resistance, but also by increases in left-ventricular mass (LVM), reduced arterial compliance and altered renal function. This investigation has examined a possible role for the renin-angiotensin system as well as body mass and insulin values in mediating these cardiovascular and renal aspects of the hypertension syndrome. METHODS: This was a cross-sectional study of 142 patients identified by community screening. Mean (+/-SE) age was 46 +/- 1 years and patients had stage I-II hypertension (blood pressure: 145 +/- 1/98 +/- 0.5 mm Hg). For analysis, patients were divided into 2 groups: those with body mass index (BMI) <27 kg/m(2) (lean, n = 72) or BMI >27 kg/m(2) (overweight, n = 70). RESULTS: By univariate analysis, LVM in lean patients correlated significantly with plasma renin activity (PRA), plasma aldosterone, BMI and systolic BP; but with multivariate regression, only PRA (p < 0.01) and BMI (p < 0.04) remained in the model as independent predictors of LVM. For LVM in overweight patients, only BMI (p < 0.02) remained in the model. For total arterial compliance (stroke volume/pulse pressure) only fasting plasma insulin (in the overweight group) was significantly related (p < 0.01). For urinary protein excretion, the only predictor in lean patients was PRA (p < 0.02), whereas in overweight patients it was BMI (p < 0.03). For creatinine clearance, BMI (p < 0.01 in overweight patients) remained in the model, though by univariate regression PRA had an age-dependent dichotomous relationship to clearance: r = +0.25 (p < 0.01) in patients <55 years, but r = -0.54 (p < 0.01) in patients > or =55 years. CONCLUSION: These findings suggest that in overweight patients cardiovascular and renal values depend chiefly on body weight and insulin, but that in normal weight hypertensives the renin-angiotensin system may play the major role.
No takes yet. Share an insight, caveat, or question.
Weber et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: